Therapeutic Area Expertise

Therapeutic area expertise is essential for the development of scientifically complex materials adapted for various target audiences. Med Communications employs highly trained scientific content specialists with experience spanning the pharmaceutical industry, academia, and diverse clinical settings with expertise in a variety of therapeutic areas. This allows us to adapt our areas of focus specifically to suit our clients’ needs. We take cutting-edge research, identify the most relevant and critical findings, and present them in a way that is informative and actionable for the intended audience, from specialists to patients. Our goal is to ensure scientifically accurate and fair balanced content from start to finish. 

Why therapeutic areas of expertise are important 

Constants shifts in the healthcare industry call for new clinical studies and the development of innovative therapies. In addition, standards of care treatments are continuously being evaluated in the context of new and emerging therapies.  

Our scientific expertise at Med Communications connects clinical experience with vast knowledge derived from our active involvement in developing scientific content for biotech and pharmaceutical markets. Utilizing high quality clinical data, we create scientifically accurate and fair balanced content that are useful to health care professionals and their patients. 


Partnering with a team that has the expertise needed to place your product on the path to success is critical at every stage of the drug development process. Med Communications strategically contributes to the success of our clients’ medical affairs projects because of our extensive expertise in the therapeutic areas discussed below.  Tap the blue boxes to learn more.

  • Oncology

    • Immuno-oncology
    • Breast cancer
    • Colon cancer
    • Renal cell carcinoma
    • Melanoma
    • Head and neck cancers
    • Prostate cancer
    • Myeloproliferative neoplasms
    • Lung cancer
    • Gastrointestinal cancer
    • Genitourinary cancer
    • Gynecological cancer
    We create content covering medical, radiation, and surgical treatment experience for various cancers, including leukemia, lymphoma, carcinoma, breast, colon, prostate, and ovarian cancers.
  • Infectious Disease

    • Influenza
    • Vaccines
    • HIV
    • Antibacterials
    • CMV
    • RSV
    We develop and review content regarding influenza, HIV, RSV, and antibacterial treatments and vaccines.
  • Women’s Health

    • Oral contraceptives
    • Hormone replacement therapy
    • Emergency contraceptive
    • Fertility/infertility
    • Vasomotor symptom reduction in menopause
    Although men and women face similar concerns regarding their health, some issues are of particular concern for women. Issues such as contraceptive use for those of childbearing potential and hormone replacement therapy during menopause are among the top ranked inquiries received and handled by our Medical Information Contact Center.
  • Cardiology

    • Hypertension
    • Acute coronary syndromes
    • Arrhythmias
    • Ischemia
    • Angina
    • Hypercholesterolemia
    • Anticoagulation antidote
  • Gastroenterology

    • H. pylori
    • GERD
    • Hypersecretory conditions
    • Ulcerative colitis
  • Pulmonology

    • Asthma
    • COPD
    • Cystic fibrosis
    • Pneumonia
    • Allergic rhinitis
    • Pulmonary arterial hypertension
  • Neurology/CNS

    • Epilepsy
    • Multiple sclerosis
    • Acute and chronic pain
    • ADHD
    • Antipsychotics
    • Muscular dystrophy
  • Biologics

    • Crohn’s disease
    • Plaque psoriasis
    • Psoriatic arthritis
    • Asthma and systemic lupus erythematosus (SLE)
  • Nephrology

    • Chronic renal disease
    • End-stage renal disease
  • Orphan Drugs/
    Rare Diseases

    • Cystic fibrosis
    • Alpha-1 antitrypsin deficiency, CAPS, PNH, VOD, and lysosomal storage disorders
    • Myelofibrosis and polycythemia
    • Medullary thyroid cancer, generalized lipodystrophy, and familial chylomicronemia syndrome
    • Hemophilia A and B
    • Biallelic RPE65 mutation
    We create specialized content for orphan drugs and a variety of rare diseases, including bleeding disorders, cardiomyopathies, and immunodeficiencies.
  • Vaccines

    • Smallpox
    • Monkeypox
    • Flu
    • Rabies
    • RSV
    • COVID-19
  • Hematology

    • Blood disorders
    • Hemophilia A (classic disease)
    • Hemophilia B (Christmas disease)
    • Hemophilia C (Factor XI deficiency)
    • Von Willebrand disease
  • Endocrinology

    • Type 2 diabetes
    • Osteoporosis
    • Menopause
    • Hypoglycemia
    • Acromegaly
    • Carcinoid tumors
  • Allergy/ENT

    • Asthma
    • Ear infections
    • Throat infections
    • Esophageal infections
  • Gene Editing

    • Muscular dystrophy
    • Cystic fibrosis
  • Medical Devices

    • Blood storage and delivery
    • Lung diagnostic imaging
    • Respiratory inhalers and spacers
    • Injection pens

*Note: This is not an exhaustive list 

Med Communications’ collective years of expertise across diverse settings uniquely positions us to provide unmatched quality that exceeds our clients’ expectations, regardless of the therapeutic area or content deliverable.  

Launch Experience

The teams at Med Communications know all the necessary elements needed during all phases of the product life cycle. On a daily basis, Med Communications assists and advises its clients to ensure successful product launches. With hundreds of product launches successfully implemented, we are ready to support you during your launch journey!